A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.
A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback